Correction to: Nature Communications https://doi.org/10.1038/s41467-020-18096-2, published online 27 August 2020
The original version of this Article contained the following error:
In the “Methods” subsection ‘Inhibition parameters’, the volume of SARS-CoV-2Mpro incubated with GC373 or GC376 was incorrectly listed as 80 mM; this has been corrected to 80 nM.
This error has been corrected in both the PDF and HTML versions of the Article.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Vuong, W., Khan, M.B., Fischer, C. et al. Author Correction: Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication. Nat Commun 11, 5409 (2020). https://doi.org/10.1038/s41467-020-19339-y
Published:
Version of record:
DOI: https://doi.org/10.1038/s41467-020-19339-y
